Picture of American Oriental Bioengineering logo

AOBI American Oriental Bioengineering Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for American Oriental Bioengineering, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2008
December 31st
C2009
December 31st
C2010
December 31st
2011
December 31st
2012
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line47.141.314.1-68.5-59.7
Depreciation
Deferred Taxes
Non-Cash Items161.835.2479.67.66
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital0.61-27-23.412.2-7.17
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities74.827.68.2130-46.5
Capital Expenditures-173-5.1-6.08-36.4-22.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-84.7-1.66-0.259-35.637.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-257-6.76-6.34-71.915.2
Financing Cash Flow Items-300.7232.760.273-6.25
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities78.41.81-3.87-4.26-15.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-98.323.13.44-41.9-45.5